Our previous study [19] and current analysis of new rhabdomyosarcoma tumor samples demonstrated that expression of MET mRNA is lower in embryonal (ERMS) than in alveolar (ARMS) subtype (Figure 1A), which is usually associated with more malignant phenotype [3]. This evidence concerns the gene MET and rhabdomyosarcoma.